These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22669610)

  • 1. Treatment of facial myokymia in multiple sclerosis with botulinum toxin.
    Habek M; Adamec I; Gabelić T; Brinar VV
    Acta Neurol Belg; 2012 Dec; 112(4):423-4. PubMed ID: 22669610
    [No Abstract]   [Full Text] [Related]  

  • 2. Spasmodic torticollis associated with multiple sclerosis: report of two cases.
    Svetel M; Sternic N; Filipovic S; Kostic V
    Mov Disord; 1997 Nov; 12(6):1092-4. PubMed ID: 9399247
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
    Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
    Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facial Myokymia and Hemifacial Spasm in Multiple Sclerosis: A Descriptive Study on Clinical Features and Treatment Outcomes.
    Marin Collazo IV; Tobin WO
    Neurologist; 2018 Jan; 23(1):1-6. PubMed ID: 29266036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nuclear magnetic resonance imaging in a case of facial myokymia with multiple sclerosis].
    Kojima S; Yagishita T; Kita K; Hirayama K; Ikehira H; Fukuda N; Tateno Y
    No To Shinkei; 1985 Jun; 37(6):583-8. PubMed ID: 4041289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin Type A Injections as an Effective Treatment of Refractory Multiple Sclerosis-Related Trigeminal Pain - A Case Report.
    Calejo M; Salgado P; Moreira B; Correia C; Barros J
    Headache; 2019 Sep; 59(8):1379-1381. PubMed ID: 31424566
    [No Abstract]   [Full Text] [Related]  

  • 7. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.
    Krohel GB; Cipollo CL; Gaddipati K
    Am J Ophthalmol; 2005 Mar; 139(3):540. PubMed ID: 15767069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myectomy and botulinum toxin for paralysis of the marginal mandibular branch of the facial nerve: a series of 76 cases.
    Chen CK; Tang YB
    Plast Reconstr Surg; 2007 Dec; 120(7):1859-1864. PubMed ID: 18090747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual variant of chorda tympani syndrome, its management, and a proposal on the nervous pathways involved.
    Hodges S; Herold J
    Br J Oral Maxillofac Surg; 2011 Oct; 49(7):e53-4. PubMed ID: 21330021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin improves dysphagia associated with multiple sclerosis.
    Restivo DA; Marchese-Ragona R; Patti F; Solaro C; Maimone D; Zappalá G; Pavone A
    Eur J Neurol; 2011 Mar; 18(3):486-90. PubMed ID: 20731706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin and facial palsy. Our experience].
    Navarrete Alvaro ML; Junyent J; Torrent L
    Acta Otorrinolaringol Esp; 2010; 61(4):277-81. PubMed ID: 20400055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of vulvodynia with botulinum toxin A.
    Tieu KD; MacGregor JL
    Arch Dermatol; 2011 Feb; 147(2):251-2. PubMed ID: 21339463
    [No Abstract]   [Full Text] [Related]  

  • 13. Botulinum toxin-induced immobilization of lower facial wounds.
    Gassner HG; Sherris DA; Friedman O
    Arch Facial Plast Surg; 2009; 11(2):140-2. PubMed ID: 19289689
    [No Abstract]   [Full Text] [Related]  

  • 14. Subjective and objective outcome measures in the treatment of facial nerve synkinesis with onabotulinumtoxinA (Botox).
    Couch SM; Chundury RV; Holds JB
    Ophthalmic Plast Reconstr Surg; 2014; 30(3):246-50. PubMed ID: 24807539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum Toxin A in bruxers. One year experience.
    Redaelli A
    Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin for urogenital conditions.
    Eccleston KJ; Woolley PD
    Int J STD AIDS; 2008 Dec; 19(12):797-9. PubMed ID: 19050206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated facial myokymia as a presenting feature of pontine neurocysticercosis.
    Bhatia R; Desai S; Garg A; Padma MV; Prasad K; Tripathi M
    Mov Disord; 2008 Jan; 23(1):135-7. PubMed ID: 17987648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A in the management of a neuropathic foot ulcer.
    Alsharqi A; Curley R; Winhoven S
    Clin Exp Dermatol; 2011 Dec; 36(8):915-6. PubMed ID: 21623883
    [No Abstract]   [Full Text] [Related]  

  • 19. Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.
    Goessaert AS; Everaert KC
    Expert Rev Neurother; 2012 Jul; 12(7):763-75. PubMed ID: 22853784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin A in anti-GAD-positive stiff-limb syndrome.
    Anagnostou E; Zambelis T
    Muscle Nerve; 2012 Sep; 46(3):457-8. PubMed ID: 22907242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.